Search the Newsreel

IperionX grows titanium powder capacity and critical minerals platform in June quarter

IperionX (ASX: IPX) significantly increased its titanium powder manufacturing capacity and successfully completed the feasibility study for its Titan project, which projects an after-tax NPV8 of US$813 million. The company's Virginia operations maintained 24/7 titanium powder production and tripled its powder metallurgy capacity. Additionally, …

IPX: Expanded titanium production and secured $50M in new funding to accelerate growth

Iperionx Ltd. (IPX) has expanded its titanium powder production and product manufacturing capacity, showing strong progress in customer programs and government-backed critical minerals projects. The company's cash position has been strengthened by a $50 million public offering, which will support ongoing scale-up and research …

NXP Semiconductors NV (NXPI) Stock Down 7.0% but Still Overvalued -- GF Score: 92/100

NXP Semiconductors NV (NXPI) saw its shares drop by 7.0% to $240.98, yet it remains 2.8% overvalued according to its GF Value™ of $234.48. Despite a strong GF Score™ of 92/100, indicating good overall performance, the stock's current P/E ratio is significantly above historical …

CXT|Crane NXT Co|Price:51.149|Chg%:-0.851

Crane NXT Co (CXT) shows stable fundamentals and high growth potential, with its valuation considered fairly valued within its industry. Analysts rate the stock as a "Buy" with a high price target, suggesting an expected upward trend. The company maintains high institutional ownership and …

J.P. Morgan Initiates CNX Resources Corp(CNX.US) With Hold Rating, Announces Target Price $38

J.P. Morgan has initiated coverage on CNX Resources Corp (CNX.US) with a "Hold" rating. The firm has set a target price of $38 for the company's stock.

Pulmonx Reports Second Quarter 2026 Financial Results

REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2026 ended June 30, 2026. Recent Highlights Achieved …

BlackRock (LUNG) updates Pulmonx Corp stake, reports 765,721 shares owned

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 765,721 shares of Pulmonx Corp (LUNG) common stock, which represents 1.8% of the class. BlackRock holds sole voting and sole dispositive power over all these shares, with no shared power. The …

ARGX|argenx SE|Price:861.810|Chg%:-20.750

This article provides a comprehensive stock analysis of argenx SE (ARGX), highlighting its relatively stable fundamentals, good growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes strong institutional ownership and a "Buy" rating from multiple analysts, with an expected …

NXP Semiconductors Q2 Earnings Beat Estimates, Revenues Rise Y/Y

NXP Semiconductors reported better-than-expected second-quarter 2026 results, driven by strong performance across its automotive, industrial, and communication infrastructure segments, with revenues increasing 19.5% year over year to $3.50 billion. The company also highlighted significant growth in its AI and data center businesses, projecting over …

NXP reveals emerging physical AI pipeline, but analysts await auto recovery

NXP Semiconductors' Q2 results and outlook exceeded expectations, yet shares declined 5% due to limited growth in the auto and mobile markets. While NXP is expanding its data center revenue and physical AI pipeline, analysts remain cautious about the near-term due to ongoing headwinds …

NXPI Q2 Earnings Call Highlights Physical AI Growth

NXP Semiconductors N.V. NXPI emphasized expanding demand across automotive, industrial and emerging artificial intelligence (AI) applications as management discussed a stronger second-half outlook following second-quarter 2026 results. Executives highlighted software-defined vehicles, edge AI, data center opportunities and improving demand signals as key drivers shaping …

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has argenex SE (ARGX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the …

NXP Semiconductors N.V. Q2 2026 Earnings Call Summary

NXP Semiconductors N.V. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance …

Bernstein Adjusts Price Target on NXP Semiconductors to $290 From $270, Maintains Market Perform Rating

Bernstein has increased its price target for NXP Semiconductors (NXPI) to $290 from $270, while reiterating a Market Perform rating on the stock. This adjustment reflects a positive outlook on the company's valuation though the overall recommendation remains neutral.

JPMorgan Adjusts Price Target on NXP Semiconductors to $300 From $295, Maintains Neutral Rating

JPMorgan has increased its price target for NXP Semiconductors (NXPI) from $295 to $300, while maintaining a Neutral rating on the stock. This adjustment reflects a modest upside potential for the company based on the new target.

Bluelinx Holdings Inc (BXC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Bluelinx Holdings Inc (BXC), noting its current valuation score of 9.54, which ranks 3 out of 54 in its industry. The company's P/E ratio is currently -120.16. The report indicates that specific data for P/B, P/S, and …

Morgan Stanley raises NXP Semiconductors price target on auto content gains

Morgan Stanley raised its price target on NXP Semiconductors NV to $338 from $335, maintaining an Overweight rating, citing content gains from software-defined vehicle architecture transitions and better-than-expected Q3 guidance. The firm acknowledged NXP's Q2 results were in line with expectations, with auto revenue …

NXP Semiconductors (NXPI) Stock Looks Stretched On Cash Flow But Reasonable On Earnings

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. NXP Semiconductors has delivered a 33.5% total return over the past five years, yet its current checks suggest the stock now sits close …

BXC|Bluelinx Holdings Inc|Price:54.270|Chg%:+0.810

This article provides a comprehensive stock analysis of Bluelinx Holdings Inc (BXC) by TradingKey, highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Homebuilding & Construction Supplies industry. Analysts have rated BXC as a "Buy" with an upside space of …

Cetera Investment Advisers Has $14.84 Million Holdings in NXP Semiconductors N.V. $NXPI

Cetera Investment Advisers increased its stake in NXP Semiconductors N.V. by 5.8% in Q1 2026, valuing its holdings at $14.84 million. NXP Semiconductors reported strong Q2 2026 results, with revenue up 19.5% year-over-year and non-GAAP EPS beating analyst expectations. Despite the positive earnings and …

argenx Bets $2.2 Billion on a Vitiligo Breakthrough: What the Forte Biosciences Deal Means for Both Stocks

The biopharma sector is in the middle of a transformation in which macroeconomic pressures and policy developments actively dictate corporate dealmaking. As leading pharmaceutical companies prepare for a $300 billion patent cliff in the second half of the decade, capital allocation has switched sharply …

REGENXBIO Inc. (RGNX) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on Shares - Guidance vs Actual

NXDR Q1 2026 Earnings: Narrowing Losses on Stronger Operating Discipline - Growth Acceleration Report

Pulmonx Q2 Earnings Call Highlights

Key Points Interested in Pulmonx Corporation? Here are five stocks we like better. Pulmonx reported $22.8 million in Q2 revenue, down 5% year over year, but U.S. revenue rose 7% sequentially as the company rebuilt its sales force and added 12 treating centers. Management …

Pulmonx (NASDAQ:LUNG) Announces Earnings Results

Earnings call transcript: Pulmonx tops Q2 2026 estimates, shares jump 14.4%

Principal Financial Group Inc. Has $5.54 Million Position in Quanex Building Products Corporation $NX

GreenX Metals (ASX: GRX): Poland Award Enforced in Singapore as Focus Shifts to Copper and Gold

NXP Semiconductors N.V. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NXPI) 2026-07-29

NXP Semiconductors N.V. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance …

NXP Semiconductors N.V. Stock 12‑Month Price Target Cut to $314.44, Implies 21% Upside

The average 12-month price target for NXP Semiconductors N.V. (NXPI) stock has been lowered slightly to $314.44 from $316.84, according to 25 analysts. This new target suggests a potential upside of approximately 21% from the July 28 closing price. The consensus rating among 30 …

Forte Biosciences (FBRX) Agrees To argenx Takeover As Tender Offer Nears

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. argenx SE has entered into a definitive agreement to acquire Forte Biosciences through a cash tender offer. The boards of both companies have approved the transaction, which …

Crane NXT Co (CXT) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of Crane NXT Co (CXT), indicating a current financial score of 6.79, ranking it 126 out of 180 in its industry with weak financial status but high operating efficiency. CXT reported a quarterly revenue of $387.70 million, …

CXT|Crane NXT Co|Price:54.530|Chg%:+0.310

This article provides a comprehensive stock analysis of Crane NXT Co (CXT) by TradingKey. It highlights the company's stable fundamentals, high growth potential, and fair valuation, with a strong institutional ownership. The analysis also mentions a positive outlook from analysts, despite technical indicators suggesting …

Pulmonx Corp. Revenue Breakdown – LSX:A2P1AF

Pulmonx Corp. (LSX:A2P1AF) generated €77.05 million in revenue last year, primarily from its Interventional Pulmonology segment. The United States was the largest contributor to revenue, accounting for €48.55 million in the past year. This report provides a breakdown of the company's financial performance by …

Can CNX Resources (NYSE:CNX) Capitalize on Rising Natural Gas Demand?

This article discusses how CNX Resources (NYSE:CNX) is positioned to capitalize on rising natural gas demand, focusing on its Appalachian production, disciplined spending, and access to infrastructure. Key factors influencing the company's outlook include production efficiency, capital allocation, environmental performance, and regional commodity conditions. …

NXP Semiconductors (NXPI) Q2 Earnings and Revenues Top Estimates

NXP Semiconductors (NXPI) came out with quarterly earnings of $3.61 per share, beating the Zacks Consensus Estimate of $3.54 per share. This compares to earnings of $2.72 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …